Syngene Q2 FY23-24 revenue from operations up 18.5% to Rs 910 Cr
Profit after tax (before exceptional items) up 23% to Rs 215 crores
Profit after tax (before exceptional items) up 23% to Rs 215 crores
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Tele-MANAS has counseled more than 3,50,000 people till date and currently provides counseling to 2000 people through 44 Tele Manas Cells
Ayush Minister launched month long ayurveda celebration drive of Ministry of Ayush
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Increased capability to produce medicines for challenging diseases including cancer
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
The medical center at the Buddh International Circuit will be under the care of the Indraprastha Apollo Hospital team
Subscribe To Our Newsletter & Stay Updated